Esperion Highlights New Exploratory Data From CLEAR Outcomes Trial Highlighting Value Of NEXLETOL In Oral Featured Science Session And Multiple Poster Presentations At AHA Scientific Sessions 2024; Exploratory Analysis Reports Patients With PAD Who...
Esperion Highlights New Exploratory Data From CLEAR Outcomes Trial Highlighting Value Of NEXLETOL In Oral Featured Science Session And Multiple Poster Presentations At AHA Scientific Sessions 2024; Exploratory Analysis Reports Patients With PAD Who...
Esperion Highlights New Exploratory Data From CLEAR Outcomes Trial Highlighting Value Of NEXLETOL In Oral Featured Science Session And Multiple Poster Presentations At AHA Scientific Sessions 2024; Exploratory Analysis Reports Patients With PAD Who Took Bempedoic Acid Were 36% Less Likely To Experience A Major Adverse Limb Event Compared To Placebo
Esperion在2024年美国心脏协会（AHA）科学会议的特色科学会议和多个海报展示中，强调了CLEAR Outcomes试验中关于NEXLETOL的新探索性数据；探索性分析报告显示，与安慰剂相比，服用苯溴马隆的外周动脉疾病（PAD）患者发生重大不良肢体事件的可能性降低了36%。
– An Exploratory Analysis Reports Patients with PAD Who Took Bempedoic Acid Were 36% Less Likely to Experience a Major Adverse Limb Event Compared to Placebo –
—— 一项探索性分析报告显示，与安慰剂相比，服用苯溴马隆的外周动脉疾病（PAD）患者发生重大不良肢体事件的可能性降低了36% ——
ANN ARBOR, Mich., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced the presentation of an analysis from the CLEAR Outcomes study focused on patients with Peripheral Artery Disease (PAD) who were unable or unwilling to take statin medications. These data were presented today in an oral featured science presentation at the 2024 American Heart Association (AHA) Scientific Sessions, which took place from November 16-18, 2024, in Chicago, IL. Additionally, two exploratory analyses from the CLEAR Outcomes trial and a real-world analysis of bempedoic acid usage were presented at the conference.
美国密歇根州安阿伯，2024年11月18日（环球新闻稿）——Esperion（纳斯达克：ESPR）今天宣布了关于CLEAR Outcomes研究的一个分析，该研究集中于无法或不愿意服用他汀药物的外周动脉疾病（PAD）患者。这些数据于2024年美国心脏协会（AHA）科学会议上以口头特色科学展示的形式进行了呈现，该会议于2024年11月16日至18日在伊利诺伊州芝加哥举行。此外，还在会议上展示了CLEAR Outcomes试验的两项探索性分析和苯溴马隆使用的现实世界分析。
热门市场机会
热门讨论
热门讨论
